Increasing linezolid resistant Enterococcus in a Children’s Hospital
The Pediatric Infectious Disease Journal:
We report a reduction in susceptibility to linezolid among Enterococcus isolates (98% in 2007 vs. 46% in 2014) in parallel with a 5- fold increase in linezolid use. A direct association could not be established as the majority of patients with linezolid non-susceptible isolates did not have prior linezolid exposure. Nosocomial transmission of the non-susceptible isolates could certainly have contributed.
No comments:
Post a Comment